United Kingdom (UK) Psoriasis Drugs Market (2025-2031) | Outlook, Forecast, Value, Analysis, Segmentation, Competitive Landscape, Share, Size & Revenue, Growth, Trends, Industry, Companies

Market Forecast By Therapeutic Class (Tumor Necrosis Factor Inhibitor, Interleukin Inhibitors), By Treatment (Topicals, Systemic, Biologics) And Competitive Landscape
Product Code: ETC9953103 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Psoriasis Drugs Market Outlook
  • Market Size of United Kingdom (UK) Psoriasis Drugs Market, 2024
  • Forecast of United Kingdom (UK) Psoriasis Drugs Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Psoriasis Drugs Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Psoriasis Drugs Market Trend Evolution
  • United Kingdom (UK) Psoriasis Drugs Market Drivers and Challenges
  • United Kingdom (UK) Psoriasis Drugs Price Trends
  • United Kingdom (UK) Psoriasis Drugs Porter's Five Forces
  • United Kingdom (UK) Psoriasis Drugs Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume By Therapeutic Class for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume By Tumor Necrosis Factor Inhibitor for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume By Interleukin Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume By Treatment for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume By Topicals for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume By Systemic for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume By Biologics for the Period 2021- 2031
  • United Kingdom (UK) Psoriasis Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Therapeutic Class
  • Market Opportunity Assessment By Treatment
  • United Kingdom (UK) Psoriasis Drugs Top Companies Market Share
  • United Kingdom (UK) Psoriasis Drugs Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Psoriasis Drugs Company Profiles
  • United Kingdom (UK) Psoriasis Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Kingdom (UK) Psoriasis Drugs Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Psoriasis Drugs Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Psoriasis Drugs Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Psoriasis Drugs Market - Industry Life Cycle

3.4 United Kingdom (UK) Psoriasis Drugs Market - Porter's Five Forces

3.5 United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F

3.6 United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F

4 United Kingdom (UK) Psoriasis Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of psoriasis in the UK population

4.2.2 Rising awareness about treatment options among patients

4.2.3 Technological advancements leading to the development of innovative psoriasis drugs

4.3 Market Restraints

4.3.1 Stringent regulations and approval process for psoriasis drugs in the UK

4.3.2 High cost associated with some advanced psoriasis treatments

4.3.3 Competition from alternative therapies such as biologics and phototherapy

5 United Kingdom (UK) Psoriasis Drugs Market Trends

6 United Kingdom (UK) Psoriasis Drugs Market, By Types

6.1 United Kingdom (UK) Psoriasis Drugs Market, By Therapeutic Class

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume, By Therapeutic Class, 2021- 2031F

6.1.3 United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume, By Tumor Necrosis Factor Inhibitor, 2021- 2031F

6.1.4 United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F

6.2 United Kingdom (UK) Psoriasis Drugs Market, By Treatment

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume, By Topicals, 2021- 2031F

6.2.3 United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume, By Systemic, 2021- 2031F

6.2.4 United Kingdom (UK) Psoriasis Drugs Market Revenues & Volume, By Biologics, 2021- 2031F

7 United Kingdom (UK) Psoriasis Drugs Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Psoriasis Drugs Market Export to Major Countries

7.2 United Kingdom (UK) Psoriasis Drugs Market Imports from Major Countries

8 United Kingdom (UK) Psoriasis Drugs Market Key Performance Indicators

8.1 Patient adherence rate to prescribed psoriasis medications

8.2 Number of clinical trials for new psoriasis drugs being conducted in the UK

8.3 Percentage of dermatologists recommending biologic treatments for psoriasis management

9 United Kingdom (UK) Psoriasis Drugs Market - Opportunity Assessment

9.1 United Kingdom (UK) Psoriasis Drugs Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F

9.2 United Kingdom (UK) Psoriasis Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F

10 United Kingdom (UK) Psoriasis Drugs Market - Competitive Landscape

10.1 United Kingdom (UK) Psoriasis Drugs Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Psoriasis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All